Furthermore, Humana continues to face pressure from rising medical costs, and its benefits expense ratio increased by 270 bps y-o-y to 89%, weighing on its stock performance. Our detailed analysis ...

Humana (NYSE:HUM ... by a significant 13% over the last month. Given that stock prices are usually aligned with a company's financial performance in the long-term, we decided to study its ...

Humana Inc.’s stock was up 2% Friday after three straight sessions of declines, but investors paying attention to the performance of its bonds on Thursday may have had something of a heads-up on ...

The company's recent financial performance has been mixed. While Humana has maintained a solid ... HUM appears on our undervalued or overvalued stock lists. These tools provide a clearer picture ...

Despite these developments, Humana's stock performance remained flat over the past week. During the same period, broader markets saw gains, bolstered by strong earnings from major tech companies.

Humana (NYSE: HUM) currently trades around ... It compares these trends to the stock’s performance during the 2008 recession. In contrast, here’s how HUM stock and the broader market performed ...

Sarah James, a stock analyst with Cantor Fitzgerald ... The lower rating won’t affect Humana’s performance until 2026, but the company said it was “disappointed with its performance and ...

The company said it is disappointed in its performance and ... Inc.” Bloomberg. “Humana Plunges as Medicare Quality Rating Drop Threatens Revenue.” Tesla Stock Rebounds After Tumble Fueled ...

Shares of Humana Inc. were suffering another beating ... insurer’s large Medicare Advantage plans because it missed some performance measures. Based on preliminary 2025 data from the Centers ...